Considerations for blinded evaluation
In open clinical trials where wound observation serves as the primary efficacy measure, we recommend the appointment of an independent blinded investigator at each trial site, accompanied by the implementation of a series of standard operating procedures (SOPs) for blinded evaluation. The ensuing considerations for blinded evaluation are explored from three perspectives: safeguarding participants' rights, minimizing bias, and optimizing clinical operability.